Long-Term Follow-up of the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed-Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Trial
Year: 2020
Type: article
Source: Blood
Authors: Koji Sasaki, Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short, Partow Kebriaei, Xuelin Huang, Nitin Jain, Marina Konopleva, Guillermo Garcia-Manero, Richard E. Champlin, Tapan M. Kadia, Koichi Takahashi, Naval Daver, Hind Rafei, Joseph D. Khoury, Jeffrey L. Jorgensen, Sa A Wang, Maria R Khouri, Jovitta Jacob, Rebecca Garris, Susan M. O'Brien, Elias Jabbour
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095263495